contentSlug

type

ContentSlug_ContentQuery

slug

ContentPageContentQuery

content

trendingContent

query ContentSlug_ContentQuery(
  $contentSlug: String!
  $type: [ContentType!]
) {
  ...ContentPageContentQuery_13QmVO
}

fragment CompanyDetails_Content on Content {
  __isContent: __typename
  companies {
    name
    description
    pageUrl
    id
  }
}

fragment ContentBasicInfo on Content {
  __isContent: __typename
  id
  type
  title
  lang
  companies {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  tags {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  ...PublishingDetails
  ...Reactions
}

fragment ContentMetadata on Content {
  __isContent: __typename
  type
  title
  lang
  pageUrl
  alternatePageUrls: translations {
    __typename
    pageUrl
    lang
  }
  imgUrl
  description
  ... on Video {
    liveTime
    videoUrl
  }
  ... on Webcast {
    liveTime
    videoUrl
  }
}

fragment ContentPageContentQuery_13QmVO on Query {
  content(slug: $contentSlug, type: $type) {
    __typename
    id
    type
    title
    isPremium
    lang
    htmlBody
    summary
    companies {
      forum {
        latestPosts {
          ...ForumPosts
        }
      }
      name
      id
      viewerIsFollowing
      pageUrl
      defaultInstrument {
        isin
        id
        marketOpen
        marketClose
        marketplace {
          region
        }
        returns {
          total
        }
      }
    }
    tags {
      viewerIsFollowing
      id
      name
      pageUrl
    }
    createdAt
    ... on Video {
      liveTime
    }
    ... on Webcast {
      liveTime
    }
    slug
    ... on CompanyReport {
      reportUrl
    }
    ... on ThirdPartyCompanyReport {
      reportUrl
    }
    ... on StockExchangeRelease {
      reportUrl
    }
    ...ContentBasicInfo
    ...ContentMetadata
    ...PriceAndRecommendation_Content
    ...CompanyDetails_Content
    ...ReportLink_Content
    ...KeyFigures_Content
  }
  ...TrendingContent_1jQ2Cn
}

fragment ForumPosts on ForumPost {
  text
  likesCount
  url
  author
  postedAt
  authorImgUrl
}

fragment KeyFigures_Content on Content {
  __isContent: __typename
  companies {
    defaultInstrument {
      estimateData {
        modelType
        reportingCurrency
      }
      snapshot {
        transaction {
          date
          actualized {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
          estimates {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
        }
      }
      id
    }
    id
  }
}

fragment PriceAndRecommendation_Content on Content {
  __isContent: __typename
  createdAt
  companies {
    name
    pageUrl
    defaultInstrument {
      priceData {
        tradeCurrency
      }
      snapshot {
        priceData {
          date
          lastPrice
          tradeCurrency
        }
        transaction {
          date
          recommendation
          targetPrice
        }
        prevTransaction {
          recommendation
        }
      }
      id
    }
    id
  }
}

fragment PublishingDetails on Content {
  __isContent: __typename
  createdAt
  publishers {
    name
    imgUrl
  }
  authors {
    __typename
    id
    name
    slug
    imgUrl
    jobTitle
  }
  ... on Video {
    liveTime
  }
  ... on Webcast {
    liveTime
  }
}

fragment Reactions on Content {
  __isContent: __typename
  id
  reactionGroups {
    reactionType
    reactionsCount
    viewerReacted
  }
}

fragment ReportLink_Content on Content {
  __isContent: __typename
  type
  isPremium
  ... on CompanyReport {
    reportUrl
  }
  ... on ThirdPartyCompanyReport {
    reportUrl
  }
  ... on StockExchangeRelease {
    reportUrl
  }
}

fragment TrendingContent_1jQ2Cn on Query {
  trendingContent(type: ARTICLE) {
    __typename
    id
    title
    lang
    pageUrl
    createdAt
    type
    imgUrl
    companies {
      squareLogoUrl
      name
      id
    }
    authors {
      __typename
      imgUrl
      id
    }
    publishers {
      imgUrl
    }
  }
}


heidi-hunter-appointed-new-vice-chair-of-the-board-of-directors-of-bavarian-nordic

__typename

title

isPremium

lang

htmlBody

summary

companies

createdAt

publishers

authors

reactionGroups

pageUrl

translations

imgUrl

description

Bavarian Nordic is a biochemistry company. Today, the company specializes in the development, manufacture, and distribution of vaccines against infectious diseases in connection with cancer treatment. In addition, vaccines against other serious diseases such as Ebola and cervical cancer are also being developed. The largest operations are located in Europe and in the U.S.  Bavarian Nordic was founded in 1994 and is headquartered in Kvistgaard, Denmark. 

Bavarian Nordic

COPENHAGEN, Denmark, December 17, 2025 – Bavarian Nordic A/S (OMX: BAVA) announced today that, following the recent appointment of Anne Louise Eberhard as new Chair of the Board of Directors...

COPENHAGEN, Denmark, December 17, 2025 – Bavarian Nordic A/S (OMX: BAVA) announced today that, following the recent appointment of Anne Louise Eberhard as new Chair of the Board of Directors, and in accordance with the Company’s Articles of Association, the Board has convened and has appointed Ms. Heidi Hunter as new Vice Chair. Ms. Hunter has been a member of the board since 2023. She has over 25 years of industry experience, working across the pharmaceutical value chain, from clinical and commercial development through to launch execution. She is formerly President at Cardinal Health, where she led the Specialty Solutions Businesses. Prior to Cardinal Health, Ms. Hunter held senior leadership positions at UCB, Boehringer Ingelheim, IQVIA and Centocor, a J&amp;J company. She also led women’s health and oncology business at Wyeth (today part of Pfizer) in the U.S. and women’s health at Novo Nordisk in Denmark. &nbsp;Ms. Hunter holds a BA from the University of Michigan and an MBA from the University of Chicago. In addition to the role as Vice Chair, Ms. Hunter’s duties on the Board include memberships of the Nomination and Compensation Committee and the Science and Technology Committee. Her external duties include board memberships with Vicore Pharma Holding AB, IO Biotech, Inc. and Sutro BioPharma Inc. The Board continues its search for a couple of candidates with relevant competencies to be nominated for election at the annual general meeting in April 2026, while at the same time securing continuity. About Bavarian Nordic Bavarian Nordic is a global vaccine company with a mission to improve health and save lives through innovative vaccines. We are a preferred supplier of mpox and smallpox vaccines to governments to enhance public health preparedness and have a leading portfolio of travel vaccines. For more information, visit <a href="https://www.globenewswire.com/Tracker?data=5Bd3DTVb3WxYFYLPU3k3tid8N7MLWAxuHiPQdpVpeopEbHx5fn6BJOEVWvfA2X7lBkbmVLVwviC0HZdDqAsFaoNRxgWKNyMyCohr1TE1lkjY6kLsOgfioFyCjW6OYUj9">www.bavarian-nordic.com</a>. Contact investors: Europe: Disa Tuominen, IR Manager, <a href="https://www.globenewswire.com/Tracker?data=pUMzRf0WGS5DEPg38MJZzotkEphnlp8LjUAPqkEwrB2nQhQEuFg8IsJdb33xnmpt7bpsI5oMEHEVJoQemLN1MK35u5TSKvHP98Ris1QTGk5x-4QHsBlfIfWWRaZ3DJev">detu@bavarian-nordic.com</a> US: Graham Morrell, Gilmartin Group, <a href="https://www.globenewswire.com/Tracker?data=vFRvxmWpRlJ6J5LSTcnntfbWHB4ir56bUQJZWodbNV5NgNzqDBGgyz26V9W7v5Rat3W-hVlS47IMB2Igr1c-JugbpixBqROpBuM1mKFuggQ=">graham@gilmartinir.com</a>, Tel: +1 781 686 9600 Contact media: Nicole Seroff, Vice President Corporate Communications, <a href="https://www.globenewswire.com/Tracker?data=8mdamkBGvX_LBw8x3ex4VSTcGwJJDAo44IcF_6Hv1BwIFfNEHpTSrqPT8UbFkrHa4V3ZrqmuVpgSUGyQ1UHKqYpg84gLKiK_dHQItoBU2E9-Oo0SD2siIZkNjX1RfSYW">nise@bavarian-nordic.com</a>, Tel: +45 53 88 06 03 Attachment<ul> <li> <a href="https://ml-eu.globenewswire.com/Resource/Download/691f5dba-5a1b-4fa4-8db0-19086c1875fa">Heidi Hunter Appointed New Vice Chair of the Board of Directors of Bavarian Nordic</a> </li> </ul><img src="https://www.globenewswire.com/newsroom/ti?nf=MTAwMTE0NTI5MCM0MDIyODQ0NDQjMjAwMDUwMg==" alt=""> <img src="https://ml-eu.globenewswire.com/media/ZTE3ZWY0ZDgtNTc1OS00ZjdkLWJlODEtOTZjZTk1MzE4ODMzLTEwMTIwNzUtMjAyNS0xMi0xNy1lbg==/tiny/Bavarian-Nordic-A-S.png" alt="">

Heidi Hunter Appointed New Vice Chair of the Board of Directors of Bavarian Nordic

Talouden myyttejä murtamassa: Saksan teollisuus on menneen talven lumia

Federal Reserven korkopäätös: Riidankylväjät vauhdissa

Taloustieteen myyttejä murtamassa: Datakeskusinvestoinnit johtavat aina vain parempaan tekoälyyn

Nousuviikko takana, USA:n työllisyystaantuma ei edelleenkään luvuissa

USA:n työllisyysluvut: Taapertaen kohti vuoden loppua